Registered entities
S Alpha Therapeutics Co., Ltd.
Reg. No. 477-81-01590South Korea
Innovation
27 patent families (5 granted) — focus: Physics & computing, Human necessities, Electricity & electronics; filing pace steady. Cited 413 times.
| Year | Filings |
|---|---|
| 2021 | 6 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 13 |
| 2025 | 15 |
| 2026 | 1 |
Investor mix
11 investors on record; lead investors include LegoChem Biosciences, Korea Investment Holdings, Stonebridge Capital, CJ Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 1 | 9% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 4 | 36% |